Paul L. Domanico

807 total citations
22 papers, 522 citations indexed

About

Paul L. Domanico is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Paul L. Domanico has authored 22 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Organic Chemistry and 3 papers in Infectious Diseases. Recurrent topics in Paul L. Domanico's work include Phosphodiesterase function and regulation (6 papers), HIV/AIDS drug development and treatment (3 papers) and Folate and B Vitamins Research (3 papers). Paul L. Domanico is often cited by papers focused on Phosphodiesterase function and regulation (6 papers), HIV/AIDS drug development and treatment (3 papers) and Folate and B Vitamins Research (3 papers). Paul L. Domanico collaborates with scholars based in United States, United Kingdom and Switzerland. Paul L. Domanico's co-authors include Yuk-Ching Tse-Dinh, Stephen J. Benkovic, Thomas A. Dix, Jeffrey M. Besterman, Gideon Bollag, Jeffrey A. Stafford, Christina R. Bourne, Jennifer M. Johnson, Adam Zlotnick and Stephen J. Stray and has published in prestigious journals such as Biochemistry, Nature Protocols and Journal of Medicinal Chemistry.

In The Last Decade

Paul L. Domanico

21 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul L. Domanico United States 14 257 113 78 64 58 22 522
Larryn W. Peterson United States 12 316 1.2× 110 1.0× 118 1.5× 35 0.5× 64 1.1× 39 498
Jay A. Markwalder United States 13 467 1.8× 146 1.3× 285 3.7× 69 1.1× 54 0.9× 18 897
Christal D. Sohl United States 16 506 2.0× 95 0.8× 50 0.6× 46 0.7× 54 0.9× 34 1.0k
Matthew Bennett United States 10 327 1.3× 78 0.7× 94 1.2× 20 0.3× 119 2.1× 12 541
Celia D’Arienzo United States 15 177 0.7× 85 0.8× 99 1.3× 47 0.7× 65 1.1× 25 513
Helena Mertlíková‐Kaiserová Czechia 18 361 1.4× 120 1.1× 211 2.7× 20 0.3× 86 1.5× 61 827
Michael Hale United States 13 329 1.3× 148 1.3× 240 3.1× 75 1.2× 73 1.3× 18 650
Michaela Serpi United Kingdom 17 444 1.7× 329 2.9× 380 4.9× 37 0.6× 157 2.7× 43 872

Countries citing papers authored by Paul L. Domanico

Since Specialization
Citations

This map shows the geographic impact of Paul L. Domanico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul L. Domanico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul L. Domanico more than expected).

Fields of papers citing papers by Paul L. Domanico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul L. Domanico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul L. Domanico. The network helps show where Paul L. Domanico may publish in the future.

Co-authorship network of co-authors of Paul L. Domanico

This figure shows the co-authorship network connecting the top 25 collaborators of Paul L. Domanico. A scholar is included among the top collaborators of Paul L. Domanico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul L. Domanico. Paul L. Domanico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Cailu, Mackenzie E. Hannum, Vicente A Ramirez, et al.. (2025). Worldwide study of the taste of bitter medicines and their modifiers. Chemical Senses. 50.
2.
Vitória, Marco, Andrew Hill, Nathan Ford, et al.. (2018). The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries. AIDS. 32(12). 1551–1561. 76 indexed citations
3.
Wring, Steve, et al.. (2016). Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate. Journal of Pharmaceutical Sciences. 106(3). 906–919. 21 indexed citations
4.
Zlotnick, Adam, et al.. (2007). In vitro screening for molecules that affect virus capsid assembly (and other protein association reactions). Nature Protocols. 2(3). 490–498. 55 indexed citations
5.
Tian, Gaochao, Warren J. Rocque, Jeffrey S. Wiseman, et al.. (1998). Dual Inhibition of Human Type 4 Phosphodiesterase Isostates by (R*,R*)-(±)-Methyl 3-Acetyl-4-[3-(cyclopentyloxy)-4-methoxyphenyl]-3- methyl-1-pyrrolidinecarboxylate. Biochemistry. 37(19). 6894–6904. 3 indexed citations
6.
Domanico, Paul L., et al.. (1996). The 384-Well Plate: Pros and Cons. SLAS DISCOVERY. 1(2). 63–64. 8 indexed citations
7.
Lutz, Michael W., et al.. (1996). Experimental design for high-throughput screening. Drug Discovery Today. 1(7). 277–286. 34 indexed citations
8.
Brackeen, Marcus F., David J. Cowan, Jeffrey A. Stafford, et al.. (1995). Design and Synthesis of Conformationally Constrained Analogs of 4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one (Ro 20-1724) as Potent Inhibitors of cAMP-Specific Phosphodiesterase. Journal of Medicinal Chemistry. 38(24). 4848–4854. 35 indexed citations
9.
10.
Stafford, Jeffrey A., Paul L. Feldman, David J. Cowan, et al.. (1995). Phosphodiesterase type IV (PDE IV) inhibition. Synthesis and evaluation of a series of 1,3,4-trisubstituted pyrrolidines. Bioorganic & Medicinal Chemistry Letters. 5(17). 1977–1982. 8 indexed citations
11.
Feldman, Paul L., Marcus F. Brackeen, David J. Cowan, et al.. (1995). Phosphodiesterase Type IV Inhibition. Structure-Activity Relationships of 1,3-Disubstituted Pyrrolidines. Journal of Medicinal Chemistry. 38(9). 1505–1510. 16 indexed citations
12.
Tian, Gaochao, J. Darren Stuart, Marcia L. Moss, et al.. (1994). 17.beta.-(N-tert-Butylcarbamoyl)-4-aza-5.alpha.-androstan-1-en-3-one Is an Active Site-Directed Slow Time-Dependent Inhibitor of Human Steroid 5.alpha.-Reductase 1. Biochemistry. 33(8). 2291–2296. 42 indexed citations
13.
Stafford, Jeffrey A., Paul L. Feldman, Brian E. Marron, et al.. (1994). Structure-activity relationships involving the catechol subunit of rolipram. Bioorganic & Medicinal Chemistry Letters. 4(15). 1855–1860. 11 indexed citations
14.
Besterman, Jeffrey M. & Paul L. Domanico. (1992). Association and metabolism of exogenously-derived lysophosphatidylcholine by cultured mammalian cells: kinetics and mechanisms. Biochemistry. 31(7). 2046–2056. 25 indexed citations
15.
Domanico, Paul L. & Yuk-Ching Tse-Dinh. (1991). Mechanistic studies on E. coli DNA topoisomerase I: Divalent ion effects. Journal of Inorganic Biochemistry. 42(2). 87–96. 45 indexed citations
16.
Shimizu, Takashi, Tatsuo Katsura, Paul L. Domanico, Silvio P. Marchese‐Ragona, & Kenneth A. Johnson. (1989). Adenosine 5'-O-(3-thiotriphosphate) hydrolysis by dynein. Biochemistry. 28(17). 7022–7027. 10 indexed citations
17.
Domanico, Paul L. & Yuk-Ching Tse-Dinh. (1988). Cleavage of dT8 and dT8 phosphorothioyl analogues by Escherichia coli DNA topoisomerase I: product and rate analysis. Biochemistry. 27(17). 6365–6371. 15 indexed citations
18.
Dix, Thomas A., Gideon Bollag, Paul L. Domanico, & Stephen J. Benkovic. (1985). Phenylalanine hydroxylase: absolute configuration and source of oxygen of the 4a-hydroxytetrahydropterin species. Biochemistry. 24(12). 2955–2958. 46 indexed citations
19.
Benkovic, Stephen J., Leslie M. Bloom, Betty J. Gaffney, et al.. (1985). On the mechanism of action of phenylalanine hydroxylase. Biochemical Society Transactions. 13(2). 436–438. 21 indexed citations
20.
Domanico, Paul L., Jubrail Rahil, & Stephen J. Benkovic. (1985). Unambiguous stereochemical course of rabbit liver fructose bisphosphatase hydrolysis. Biochemistry. 24(7). 1623–1628. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Larryn W. Peterson Breakdown of academic impact, for papers by Jay A. Markwalder Breakdown of academic impact, for papers by Christal D. Sohl Breakdown of academic impact, for papers by Matthew Bennett Breakdown of academic impact, for papers by Celia D’Arienzo Breakdown of academic impact, for papers by Helena Mertlíková‐Kaiserová Breakdown of academic impact, for papers by Michael Hale Breakdown of academic impact, for papers by Michaela Serpi
Rankless by CCL
2026